Wednesday, November 21, 2018
News

Mylan launches hepatitis B pill in India

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | Thursday, 2017 9:15:06 PM IST
Global drug firm Mylan on Thursday launched a tablet for the treatment of chronic hepatitis B among adults, the first in eight years to be approved for the management of chronic disease in India.

The tablets -- tenofovir alafenamide (TAF) -- was launched under the brand name "HepBest".

As compared to the earlier formulation of tenofovir (tenofovir disoproxil fumarate), TAF was found to have better efficacy with an enhanced renal as well as bone safety profile.

TAF also has greater plasma stability, which ensures efficient drug delivery to the site of action.

"India has an estimated 40 million HBV carriers, of which 15 per cent to 25 per cent could go on to suffer from cirrhosis and liver cancer," Rakesh Bamzai, President, India and Emerging Markets said, in a statement.

"By bringing the best-in-class drug for hepatitis B management to India, Mylan hopes to provide care for chronic hepatitis B patients and improve overall management of the disease."

Over two billion people worldwide are infected with the hepatitis B virus (HBV), of which more than 240 million have chronic liver infection, according to the World Health Organization (WHO).

These patients are at risk of developing serious illness and death, largely resulting from liver cirrhosis and liver cancer.

In 2014, Mylan had signed an agreement with Gilead to enhance access to TAF-based HIV treatments in developing countries.

As part of the licensing agreement, on US Food and Drug Administration (FDA) approval, Mylan received a technology transfer from Gilead, enabling it to manufacture low-cost versions of TAF, the statement said.

--IANS rt/him/vm

( 269 Words)

2017-12-07-20:44:08 (IANS)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
IIT-H developing ML-based sensors to che...
World's first total-body scanner produce...
Depressed people may have poor blood flo...
Clinical trial finds new immunotherapy i...
Millennial stress load - and how to over...
Depression linked to increased risk of i...
More...
 
INDIA WORLD ASIA
Kejriwal attack: Delhi govt accuses Delh...
Amit Shah's tweet on Sabarimala unfounde...
CM moves resolution seeking 33 pc quota ...
Odisha bus mishap: CM announces Rs 2 lak...
India is a country of storytellers: Rajy...
Muzaffarpur shelter home: CBI arrests do...
More...    
 
 Top Stories
IIT-H developing ML-based sensors t... 
Moody's downgrades Sri Lanka's rati... 
Amit Shah's tweet on Sabarimala unf... 
CM moves resolution seeking 33 pc q... 
Odisha bus mishap: CM announces Rs ... 
Ambassadors of India, China call on... 
India is a country of storytellers:... 
Kejriwal attack: Delhi govt accuses...